N-[2-[2-[4-[4-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]cyclohexyl]piperazin-1-yl]ethoxy]ethyl]-2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxobenzo[de]isoquinolin-5-yl]oxyacetamide

C50H52N10O8 — CID 155445821

IUPACN-[2-[2-[4-[4-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]cyclohexyl]piperazin-1-yl]ethoxy]ethyl]-2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxobenzo[de]isoquinolin-5-yl]oxyacetamide
SMILESNc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2C1CCC(N2CCN(CCOCCNC(=O)COc3cc4c5c(cccc5c3)C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)CC1
InChIInChI=1S/C50H52N10O8/c51-46-44-45(31-9-15-36(16-10-31)68-35-6-2-1-3-7-35)56-60(47(44)54-30-53-46)34-13-11-33(12-14-34)58-22-20-57(21-23-58)24-26-66-25-19-52-42(62)29-67-37-27-32-5-4-8-38-43(32)39(28-37)50(65)59(49(38)64)40-17-18-41(61)55-48(40)63/h1-10,15-16,27-28,30,33-34,40H,11-14,17-26,29H2,(H,52,62)(H2,51,53,54)(H,55,61,63)
InChIKeyRIEVRTOMURGUOJ-UHFFFAOYSA-N
MW921.03 g/mol
LogP4.74
Rot. Bonds15

About N-[2-[2-[4-[4-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]cyclohexyl]piperazin-1-yl]ethoxy]ethyl]-2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxobenzo[de]isoquinolin-5-yl]oxyacetamide

N-[2-[2-[4-[4-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]cyclohexyl]piperazin-1-yl]ethoxy]ethyl]-2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxobenzo[de]isoquinolin-5-yl]oxyacetamide (PubChem CID 155445821) has the molecular formula C50H52N10O8 and a molecular weight of 921.03 g/mol. Its IUPAC name is N-[2-[2-[4-[4-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]cyclohexyl]piperazin-1-yl]ethoxy]ethyl]-2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxobenzo[de]isoquinolin-5-yl]oxyacetamide.

Molecular Properties

Compound NameN-[2-[2-[4-[4-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]cyclohexyl]piperazin-1-yl]ethoxy]ethyl]-2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxobenzo[de]isoquinolin-5-yl]oxyacetamide
PubChem CID155445821
Molecular FormulaC50H52N10O8
Molecular Weight921.03 g/mol
Exact Mass920.40
IUPAC NameN-[2-[2-[4-[4-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]cyclohexyl]piperazin-1-yl]ethoxy]ethyl]-2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxobenzo[de]isoquinolin-5-yl]oxyacetamide
SMILESNc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2C1CCC(N2CCN(CCOCCNC(=O)COc3cc4c5c(cccc5c3)C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)CC1
InChIInChI=1S/C50H52N10O8/c51-46-44-45(31-9-15-36(16-10-31)68-35-6-2-1-3-7-35)56-60(47(44)54-30-53-46)34-13-11-33(12-14-34)58-22-20-57(21-23-58)24-26-66-25-19-52-42(62)29-67-37-27-32-5-4-8-38-43(32)39(28-37)50(65)59(49(38)64)40-17-18-41(61)55-48(40)63/h1-10,15-16,27-28,30,33-34,40H,11-14,17-26,29H2,(H,52,62)(H2,51,53,54)(H,55,61,63)
InChIKeyRIEVRTOMURGUOJ-UHFFFAOYSA-N
XLogP4.74
TPSA216.44 Ų
H-Bond Donors3
H-Bond Acceptors15
Rotatable Bonds15
Heavy Atoms68
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500921.03
LogP ≤ 54.74
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1015

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze N-[2-[2-[4-[4-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]cyclohexyl]piperazin-1-yl]ethoxy]ethyl]-2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxobenzo[de]isoquinolin-5-yl]oxyacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[2-[2-[4-[4-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]cyclohexyl]piperazin-1-yl]ethoxy]ethyl]-2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxobenzo[de]isoquinolin-5-yl]oxyacetamide?
The IUPAC name of N-[2-[2-[4-[4-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]cyclohexyl]piperazin-1-yl]ethoxy]ethyl]-2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxobenzo[de]isoquinolin-5-yl]oxyacetamide (CID 155445821) is N-[2-[2-[4-[4-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]cyclohexyl]piperazin-1-yl]ethoxy]ethyl]-2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxobenzo[de]isoquinolin-5-yl]oxyacetamide.
What is the SMILES notation for N-[2-[2-[4-[4-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]cyclohexyl]piperazin-1-yl]ethoxy]ethyl]-2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxobenzo[de]isoquinolin-5-yl]oxyacetamide?
The canonical SMILES for N-[2-[2-[4-[4-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]cyclohexyl]piperazin-1-yl]ethoxy]ethyl]-2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxobenzo[de]isoquinolin-5-yl]oxyacetamide is Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2C1CCC(N2CCN(CCOCCNC(=O)COc3cc4c5c(cccc5c3)C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)CC1.
What is the InChIKey of N-[2-[2-[4-[4-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]cyclohexyl]piperazin-1-yl]ethoxy]ethyl]-2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxobenzo[de]isoquinolin-5-yl]oxyacetamide?
The InChIKey is RIEVRTOMURGUOJ-UHFFFAOYSA-N. The full InChI is InChI=1S/C50H52N10O8/c51-46-44-45(31-9-15-36(16-10-31)68-35-6-2-1-3-7-35)56-60(47(44)54-30-53-46)34-13-11-33(12-14-34)58-22-20-57(21-23-58)24-26-66-25-19-52-42(62)29-67-37-27-32-5-4-8-38-43(32)39(28-37)50(65)59(49(38)64)40-17-18-41(61)55-48(40)63/h1-10,15-16,27-28,30,33-34,40H,11-14,17-26,29H2,(H,52,62)(H2,51,53,54)(H,55,61,63).
What are the key properties of N-[2-[2-[4-[4-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]cyclohexyl]piperazin-1-yl]ethoxy]ethyl]-2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxobenzo[de]isoquinolin-5-yl]oxyacetamide?
N-[2-[2-[4-[4-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]cyclohexyl]piperazin-1-yl]ethoxy]ethyl]-2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxobenzo[de]isoquinolin-5-yl]oxyacetamide has a molecular weight of 921.03 g/mol, XLogP of 4.74, 15 rotatable bonds, 3 hydrogen bond donors, and 15 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-[2-[4-[4-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]cyclohexyl]piperazin-1-yl]ethoxy]ethyl]-2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxobenzo[de]isoquinolin-5-yl]oxyacetamide is sourced from PubChem (CID 155445821), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).